Russell 3000

E.JeanSavage

E. Jean Savage

Trinity Industries, Inc. Jean Savage is CEO and President of Trinity Industries since February 2020. She was previously the vice president of the Surface Mining & Technology division of Caterpillar,

E. Jean Savage Read More »

Trinity Industries, Inc. Jean Savage is CEO and President of Trinity Industries since February 2020. She was previously the vice president of the Surface Mining & Technology division of Caterpillar,

ElizabethBarrett

Elizabeth A. Barrett

UroGen Pharma Ltd. Elizabeth Barrett brings to her CEO post at UroGen extensive experience leading business organizations and Fortune 500 pharmaceutical companies. Prior to UroGen, Liz was CEO of Novartis

Elizabeth A. Barrett Read More »

UroGen Pharma Ltd. Elizabeth Barrett brings to her CEO post at UroGen extensive experience leading business organizations and Fortune 500 pharmaceutical companies. Prior to UroGen, Liz was CEO of Novartis

MartineRothblatt

Dr. Martine A. Rothblatt Ph.D.

United Therapeutics Dr. Martine A. Rothblatt is Chair, CEO & Founder of United Therapeutics Corp., a Chief Executive Officer at Revivicor, Inc. and a President & CEOat Lung Biotechnology PBC.

Dr. Martine A. Rothblatt Ph.D. Read More »

United Therapeutics Dr. Martine A. Rothblatt is Chair, CEO & Founder of United Therapeutics Corp., a Chief Executive Officer at Revivicor, Inc. and a President & CEOat Lung Biotechnology PBC.

NancySimonian

Dr. Nancy A. Simonian M.D.

Syros Pharmaceuticals Nancy is the founding CEO of Syros and has an established track record of value creation in biotechnology. Prior to Syros, she was chief medical officer at Millennium

Dr. Nancy A. Simonian M.D. Read More »

Syros Pharmaceuticals Nancy is the founding CEO of Syros and has an established track record of value creation in biotechnology. Prior to Syros, she was chief medical officer at Millennium

EmilyLeProust

Dr. Emily Marine Leproust Ph.D.

Twist Bioscience Dr. Emily Marine Leproust is CEO and Founder of Twist Bioscience. As an early pioneer in the high-throughput synthesis and sequencing of DNA, she is disrupting the process

Dr. Emily Marine Leproust Ph.D. Read More »

Twist Bioscience Dr. Emily Marine Leproust is CEO and Founder of Twist Bioscience. As an early pioneer in the high-throughput synthesis and sequencing of DNA, she is disrupting the process

HelenTorley

Dr. Helen I. Torley

Halozyme Therapeutics Dr. Helen Torley brings extensive commercial and business experience as well as an extensive knowledge of the biotechnology industry to her roles as President and CEO. Throughout her

Dr. Helen I. Torley Read More »

Halozyme Therapeutics Dr. Helen Torley brings extensive commercial and business experience as well as an extensive knowledge of the biotechnology industry to her roles as President and CEO. Throughout her

HelenSabzevari

Dr. Helen Sabzevari Ph.D.

Precigen As President and CEO of Precigen and a member of its Board of Directors, Dr. Helen Sabzevari brings extensive expertise in research and development of immunotherapy-based therapeutics and in

Dr. Helen Sabzevari Ph.D. Read More »

Precigen As President and CEO of Precigen and a member of its Board of Directors, Dr. Helen Sabzevari brings extensive expertise in research and development of immunotherapy-based therapeutics and in

JacqualynFouse scaled

Dr. Jacqualyn A. Fouse Ph.D.

Agios Pharmaceuticals Dr. Jacqualyn Fouse is Chair & CEO of Agios, a company dedicated to developing small-molecule anti-cancer therapeutics. She previously served as president, chief operating officer and board member

Dr. Jacqualyn A. Fouse Ph.D. Read More »

Agios Pharmaceuticals Dr. Jacqualyn Fouse is Chair & CEO of Agios, a company dedicated to developing small-molecule anti-cancer therapeutics. She previously served as president, chief operating officer and board member

JacquelineShea

Dr. Jacqueline Elizabeth Shea Ph.D.

Inovio Pharmaceuticals, Inc. Dr. Jacqueline Shea has served as INOVIO’s President and CEO since May 2022. A molecular biologist and cell cycle geneticist by training, Jacqueline has dedicated much of

Dr. Jacqueline Elizabeth Shea Ph.D. Read More »

Inovio Pharmaceuticals, Inc. Dr. Jacqueline Shea has served as INOVIO’s President and CEO since May 2022. A molecular biologist and cell cycle geneticist by training, Jacqueline has dedicated much of

Lan Huang 1 e1633820196602

Dr. Lan Huang Ph.D.

BeyondSpring, Inc. Dr. Lan Huang is Co-founder, Chair and CEO of BeyondSpring. Dr. Huang has more than a decade of entrepreneurial experience in the Chinese and U.S. biotechnology industry and

Dr. Lan Huang Ph.D. Read More »

BeyondSpring, Inc. Dr. Lan Huang is Co-founder, Chair and CEO of BeyondSpring. Dr. Huang has more than a decade of entrepreneurial experience in the Chinese and U.S. biotechnology industry and

Register for this year’s Action for Impact Summit happening on September 25, 2024!